Rising Biosciences Inc (RBII)

[sweet crude]

RSII Investor Interest Rising (article)

Rising India (RSII) Sees Investor Interest Rise on their CBD Therapy

(NEW YORK)–Rising India, Inc. (OTC:RSII), a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, sees investor interest rise on trial launch of cancer therapy drug Cannophen™.

One of the first products to draw attention of traders to RSII was their TSW product for muscle and joint pain, back pain, neuropathy/nerve pain and arthritis. TSW Pain, a topical pain relief cream for muscle and joint relief, is currently under testing to meet FDA requirements.

With the explosive epidemic of opioid addiction sweeping this country any alternative pain therapy away from these awful medications is sure to catch attention of investors, and TSW Pain is something to watch.

http://www.wallstreetnewscast.com/rsii-0318/